Skip to main content
Dates: May 14 [Wed] - 16 [Fri], 2014
Venue: Tokyo Big Sight Organised by: Reed Exhibitions Japan Ltd.
Co-held with: 1st Personalised Medicine & Diagnostics Expo (IVD Japan 2014)
Professor and Director,
Dept. of Medicine and Biosystemic Science, Faculty of Medicine,
[Abstract]Acute leukemia has its origins in rare leukemic stem cells (LSCs) with self-renewal activity. Especially in human acute myeloid leukemias, LSCs were identified, and they can reconstitute human leukemias in immunodeficient mice. New approaches for targeting such LSCs to obtain complete cure of the disease will be presented.
Vice President, General Manager,
Chugai Pharmaceutical Co., Ltd.
[Abstract]We have succeeded in establishing pure cancer stem cell (CSC) lines from human colon cancer. CSCs possess abilities to self-replicate and generate differentiated progenies leading to reconstitution of tumor hierarchy even from a single cell. In addition, CSCs can transition between proliferating and non-proliferating drug-resistant states. Drug discovery targeting CSCs will be introduced.
-(Honorifics omitted) Please note that the speakers and programs are subject to change.The photographic and video recording rights are reserved to the Show Management.About BIO tech 2013 email@example.com